Gene-modified white blood cell infusions
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gene-modified white blood cell infusions, covering 2012-03-15 to 2012-03-15. Get the full timeline:
Most recent: Clinical Trial Update: Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma [Phase 1]